BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1086 related articles for article (PubMed ID: 18573856)

  • 1. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Minhas R; Sheikh A; Brindle P
    BMJ; 2008 Jun; 336(7659):1475-82. PubMed ID: 18573856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2013 May; 346():f2573. PubMed ID: 23641033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; May M; Brindle P
    BMJ; 2007 Jul; 335(7611):136. PubMed ID: 17615182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database.
    Hippisley-Cox J; Coupland C; Robson J; Brindle P
    BMJ; 2010 Dec; 341():c6624. PubMed ID: 21148212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ; 2017 May; 357():j2099. PubMed ID: 28536104
    [No Abstract]   [Full Text] [Related]  

  • 6. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study.
    Collins GS; Altman DG
    BMJ; 2009 Jul; 339():b2584. PubMed ID: 19584409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study.
    Collins GS; Altman DG
    BMJ; 2010 May; 340():c2442. PubMed ID: 20466793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore.
    Hippisley-Cox J; Coupland C; Robson J; Sheikh A; Brindle P
    BMJ; 2009 Mar; 338():b880. PubMed ID: 19297312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2.
    Collins GS; Altman DG
    BMJ; 2012 Jun; 344():e4181. PubMed ID: 22723603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a U.K. tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited).
    Tillin T; Hughes AD; Whincup P; Mayet J; Sattar N; McKeigue PM; Chaturvedi N;
    Heart; 2014 Jan; 100(1):60-7. PubMed ID: 24186564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting risk of emergency admission to hospital using primary care data: derivation and validation of QAdmissions score.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2013 Aug; 3(8):e003482. PubMed ID: 23959760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study.
    Hippisley-Cox J; Coupland C; Vinogradova Y; Robson J; Brindle P
    Heart; 2008 Jan; 94(1):34-9. PubMed ID: 17916661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Nov; 359():j5019. PubMed ID: 29158232
    [No Abstract]   [Full Text] [Related]  

  • 14. Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores.
    Hippisley-Cox J; Coupland C
    BMJ; 2009 Nov; 339():b4229. PubMed ID: 19926696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the risk of chronic Kidney Disease in men and women in England and Wales: prospective derivation and external validation of the QKidney Scores.
    Hippisley-Cox J; Coupland C
    BMC Fam Pract; 2010 Jun; 11():49. PubMed ID: 20565929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of QMortality risk prediction algorithm to estimate short term risk of death and assess frailty: cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2017 Sep; 358():j4208. PubMed ID: 28931509
    [No Abstract]   [Full Text] [Related]  

  • 17. The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study.
    Hippisley-Cox J; Coupland C; Brindle P
    BMJ Open; 2014 Aug; 4(8):e005809. PubMed ID: 25168040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores.
    Hippisley-Cox J; Coupland C
    BMJ; 2014 Jul; 349():g4606. PubMed ID: 25069704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of risk prediction equations to estimate future risk of heart failure in patients with diabetes: a prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ Open; 2015 Sep; 5(9):e008503. PubMed ID: 26353872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of risk prediction algorithm (QThrombosis) to estimate future risk of venous thromboembolism: prospective cohort study.
    Hippisley-Cox J; Coupland C
    BMJ; 2011 Aug; 343():d4656. PubMed ID: 21846713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.